Search | Invivogen

Recombinant human G-CSF protein - Bioactive cytokine

Recombinant cytokine, source: E. coli

Recombinant human G-CSF detection by SDS-PAGE

Cellular response to human G-CSF

G-CSF signaling inhibition

Recombinant human IL-9 protein - Bioactive cytokine

Recombinant cytokine, source: CHO cells

Human IL-9 SDS-PAGE analysis

Dose-response of HEK-Blue™ IL-9 cells to recombinant human IL-9 cytokine

Dose-dependent inhibition of HEK-Blue™ IL-9 cell response using Enokizumab biosimilar

Human PD-L2 (CD273) Antibody (clone 24F.10C12)

Mouse IgG2a - Recombinant

Disruption of PD-1/PD-L2 inhibitory interaction using Anti-hPD-L2 mAb

Validation of Anti-PD-L2 mA by flow cytometry

Human IL-31R (IL-31RA) Antibody - Nemolizumab Biosimilar

Human IgG2 - CAS #1476039-58-3

Neutralization of hIL-31 signaling using Nemolizumab

Human IL-33R (ST2) Antibody - Astegolimab Biosimilar

Human IgG2 - CAS #2173054-79-8

Neutralization of IL-33 signaling using Astegolimab biosimilar

Human IL-18 Antibody - Camoteskimab Biosimilar

Human IgG1 Fc silent - CAS #2492472-82-7

Neutralization of hIL-18 signaling using Camoteskimab

Human IL-17A Antibody - Secukinumab Biosimilar

Human IgG1 - CAS #1229022-83-6

Dose-dependent inhibition of HEK-Blue™ IL-17 cell response using Secukinumab biosimilar

Human IL-36R Antibody - Imsidolimab Biosimilar

Human IgG4 (S228P) - CAS #2102543-86-0

Neutralization of human IL-36 signaling using Imsidolimab

Recombinant human IFN-β protein - Bioactive cytokine

Recombinant cytokine, source: CHO cells

SDS-PAGE analysis of recombinant human (h)IFN-β

Dose-response of HEK-Blue™ IFN-α/β cells to recombinant human (h)IFN-β

Dose-dependent inhibition of IFN-β signaling in HEK-Blue™ IFN-α/β cells using Anifrolumab biosimilar

Human IL-22 Antibody - Fezakinumab Biosimilar

Human IgG1 - CAS #1007106-86-6

Dose-dependent inhibition of HEK-Blue™ IL-22 cell response using Fezakinumab biosimilar

Recombinant human IL-20 protein - Bioactive cytokine

Recombinant cytokine, source: CHO cells

Dose-response of HEK-Blue™ IL-19/IL-20 cells to recombinant human IL-20 cytokine

Human IL-20 SDS-PAGE analysis

Neutralization of cellular response to IL-20 using Fletikumab biosimilar

Human IL-20 Antibody - Fletikumab Biosimilar

Human IgG4 (S228P) - CAS #1357158-22-5

Neutralization of cellular response to IL-20 using Fletikumab biosimilar

Human IL-5R Antibody - Benralizumab Biosimilar

Human IgG1 afucosylated - CAS #1044511-01-4

Dose-dependent inhibition of IL-5 signaling using Benralizumab biosimilar

Recombinant human IL-5 protein - Bioactive cytokine

Recombinant cytokine, source: CHO cells

Dose-response of HEK-Blue™ IL-5 cells to recombinant IL-5

Recombinant human IL-5 detection by SDS-PAGE

Dose-dependent inhibition of IL-5 signaling using Benralizumab biosimilar

Human IL-21 Antibody - Avizakimab Biosimilar

Human IgG1 - CAS #2229685-51-0

Dose-dependent inhibition of IL-21 signaling using Avizakimab biosimilar

Human IL-10 Antibody

Human IgG1 (clone 20G2) - Recombinant

Neutralization of IL-10 signaling using Anti-hIL-10-hIgG1 antibody

Recombinant human IL-29 (IFNλ1) protein - Bioactive cytokine

Recombinant cytokine, source: CHO cells

Recombinant human IL-29 detection by SDS-PAGE

Dose-response of HEK-Blue™ IFN-λ cells to recombinant IL-29 cytokine

Neutralization of IL-29 signaling using Anti-hIL-29-mIgG1 antibody

Human APRIL Antibody - Sibeprenlimab Biosimilar

Human IgG2 - CAS #2382896-07-1

Dose-dependent neutralization of APRIL signaling through the BCMA receptor

Human BAFF Antibody - Belimumab Biosimilar

Human IgG1 - CAS #356547-88-1

Dose-dependent neutralization of BAFF signaling through the BCMA receptor

Recombinant human APRIL/TNFSF13 protein - Bioactive cytokine

Recombinant cytokine, source: HEK293 cells

SDS-PAGE analysis of recombinant human APRIL

Dose-response of HEK-Blue™ BCMA cells to recombinant human APRIL

Dose-dependent inhibition of HEK-Blue™ BCMA cell response using Sibeprenlimab biosimilar